In Brief: Twenty First Century Health
This article was originally published in The Gray Sheet
Executive Summary
Twenty First Century Health: Las Vegas-based firm resumes trading on the OTC Bulletin Board Feb. 25 following a ten-day suspension stemming from an ongoing inquiry by the Securities and Exchange Commission into the firm's non-invasive glucose meter technology and other financial issues. SEC questions "the adequacy and accuracy of publicly disseminated information" relating to: TFCH's financial condition; the existence, effectiveness and marketability of TFCH's glucose monitor and its potential market; and "the ownership, value and business of certain companies purportedly acquired by TFCH," the agency states. TFCH says it plans to fully comply with the investigation by completing an audit report and submitting other requisite financial material to the National Association of Securities Dealers. TFCH also notes it plans to submit to FDA a 510(k) for the glucose monitor...